0001179110-20-011223.txt : 20201119
0001179110-20-011223.hdr.sgml : 20201119
20201119164823
ACCESSION NUMBER: 0001179110-20-011223
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201109
FILED AS OF DATE: 20201119
DATE AS OF CHANGE: 20201119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sorg Elaine K.
CENTRAL INDEX KEY: 0001832571
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 201329345
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
3
1
edgar.xml
FORM 3 -
X0206
3
2020-11-09
0
0001551152
AbbVie Inc.
ABBV
0001832571
Sorg Elaine K.
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
Sr. V.P., U.S. Commercial Ops.
Common Stock, $0.01 par value
17595
D
Option(Right to buy)
114.36
2028-02-14
Common Stock
7080
D
Option(Right to buy)
79.02
2029-02-20
Common Stock
10384
D
Option(Right to buy)
93.50
2030-02-19
Common Stock
45009
D
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 2,360 shares on 2/15/2019, as to 2,360 shares on 2/15/2020 and becomes exercisable as to 2,360 shares on 2/15/2021.
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 5,192 shares on 2/21/2020 and becomes exercisable as to 5,192 shares on 2/21/2021, and as to 5192 shares on 2/21/2022.
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable as to 15,003 shares on 02/20/2021, as to 15,003 shares on 2/21/2022, and as to 15,003 shares on 2/21/2023.
Steven L. Scrogham, attorney-in-fact for Elaine K. Sorg
2020-11-19
EX-24
2
ex24sorg.txt
SORG POA
POWER OF ATTORNEY
The undersigned constitutes and appoints LAURA J. SCHUMACHER, JENNIFER
M. LAGUNAS, EMILY A. WEITH and STEVEN L. SCROGHAM, and each of them
individually, as the undersigned's true and lawful attorney-in-fact and agent,
with full power of substitution and re-substitution, for the undersigned and in
the undersigned's name, place and stead, to prepare and sign any and all
Securities and Exchange Commission ("SEC") Notices of Proposed Sales of
Securities pursuant to Rule 144 under the Securities Act of 1933 on Form 144,
all SEC statements on Forms 3, 4 and 5 as required under Section 16(a) of the
Securities Exchange Act of 1934, including a Form ID and any other documents
necessary to obtain codes and passwords necessary to make electronic filings,
and any amendments or successors to such forms, and to file the same with all
exhibits thereto, and other documents in connection therewith, with the SEC,
granting unto said attorney-in-fact and agent full power and authority to do
and perform each act and thing requisite, necessary or desirable to be done
under said Rule 144 and Section 16(a), as fully for all intents and purposes as
the undersigned might or could do in person, hereby ratifying and confirming
all that said attorney-in-fact and agent may lawfully do or cause to be done by
virtue hereof.
A copy of this power of attorney shall be filed with the SEC. The
authorization set forth above shall continue in full force and effect until the
undersigned is no longer required to file Forms 144, 3, 4, or 5 or if earlier,
until the undersigned revokes such authorization by written instructions to the
attorney-in-fact.
Date: Nov. 10, 2020
/s/ Elaine K. Sorg
------------------------------
Elaine K. Sorg
------------------------------
Name
AbbVie Inc.
1 N. Waukegan Road
North Chicago, IL 60064